Companies / IO Biotech, Inc.

IO Biotech, Inc.

Foreign · IFRSCIK 1865494COPENHAGEN

Financials

Revenue
Net income$-95.49M
Total debt$16.66M
Cash$30.66M
Diluted EPS$-1.45
Shares outstanding71.9M

Ownership

71.9M shares outstanding · as of Nov 10, 2025
6.3%10%+ / strategic
Ownership
10%+ / strategic6.31%4,543,532
Institutions11.29%8,123,930
Public float82.39%59,281,380

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 23

View all →

Activity

Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Novo Holdings A/S
13F manager
ExitCommon stock$-1.53M-2.5M
-100.00%
0
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
ExitCommon stock$-126.4K-208K
-100.00%
0
low
Q1 2026
as of
Bridgeway Capital Management, LLC
13F manager
ExitCommon stock$-45.7K-75K
-100.00%
0
low
Q1 2026
as of
Marshall Wace, LLP
13F manager
TrimCommon stock$-7.7K-128K
-29.82%
301,291
0.42% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
AddCommon stock$3.3K+55K
+39.97%
194,158
0.27% of shares
low
Q1 2026
as of
Gsa Capital Partners LLP
13F manager
NewCommon stock$20+348K
348,352
0.48% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Point72 Asset Management, L.P.Passive13G
Chernett JoreyPassive13G/A4,543,532
HBM Healthcare Investments (Cayman) Ltd.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
449778109